Lack of interference of icodextrin on creatinine measurements.
Glucose has been reported to interfere in the analysis of creatinine by the Jaffe method. The potential interference of icodextrin and its primary metabolites (maltose, maltotriose, maltotetraose) on creatinine measurements has not previously been addressed. We evaluated the potential interference of icodextrin and its metabolites at various concentrations using both the Jaffe and Creatinine Plus methods. Interference was determined in samples containing 0.6-20 mg/dL creatinine in saline solution or in plasma (n = 6), and in dialysate samples (n = 6) spiked with icodextrin, maltose, maltotriose, and maltotetraose at concentrations up to twofold the level found in plasma and dialysate from patients treated using icodextrin. Results confirm that no interference occurs when using either the colorimetric Jaffe method or the enzymatic Creatinine Plus method at levels up to 65 g/L icodextrin, 2 g/L maltose, 2 g/L maltotriose, and 1 g/L maltotetraose, levels representing worst-case clinical concentrations. In addition, our results confirm that comparable values can be obtained using either the Jaffe or the Creatinine Plus method for the analysis of creatinine in uremic plasma and in dialysate samples.
Burke
R A
RA
Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois, USA.
Hughes
G
G
Moberly
J B
JB
D003404:Creatinine / Q000378:metabolism*; D015314:Dialysis Solutions / Q000494:pharmacology*; D005936:Glucans / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D000077607:Icodextrin; D008320:Maltose / Q000031:analogs & derivatives / Q000494:pharmacology; D009844:Oligosaccharides / Q000494:pharmacology; D014312:Trisaccharides / Q000494:pharmacology; D014462:Ultrafiltration
D015314:Dialysis Solutions; D005936:Glucans; D009844:Oligosaccharides; D014312:Trisaccharides; D000077607:Icodextrin; C008317:maltotriose; D008320:Maltose; D003404:Creatinine; C009819:maltotetraose; D005947:Glucose